Answers are grounded in this paper and cite their sources.
Biochemical study demonstrates the assembly of potent inhibitors in HIV-1 protease, suggesting that target-templated click chemistry can produce high-affinity therapeutics.
Twice poor equals potent: HIV-1 Protease assembles its own potent inhibitor through formation of the triazole linkage from azide- and alkyne-containing fragments that are themselves poor binders.
No takes yet. Share an insight, caveat, or question.
Whiting et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: